News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Multiple Brokers Raise TPs as Intel Quarterly Results Beat; HSBC Research Lifts TP to US$100
Intel (INTC.US)'s 1Q26 results beat expectations. Multiple brokers raised their target prices, as listed below:Broker | Rating | Target Price (USD)JPMorgan | Underweight | 35 &...
Reset
Send
The window will close in 5 seconds
<Research>Multiple Brokers Raise TPs as Intel Quarterly Results Beat; HSBC Research Lifts TP to US$100
Close
Recommend
8
Positive
9
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

Intel (INTC.US)      's 1Q26 results beat expectations. Multiple brokers raised their target prices, as listed below:

Broker | Rating | Target Price (USD)
JPMorgan | Underweight | 35 → 45
UBS | Neutral | 65 → 83
Jefferies | Hold | 60 → 80
Bernstein | Equalweight | 60 → 65
HSBC Global Research | Buy | 95 → 100
Morgan Stanley | Equalweight | 56 → 73
(Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Related NewsPersonal Income MoM for Apr in United States is 0%, lower than the previous value of 0.6%. The forecast was 0.4%.

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.